Home » Archive by Category

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

Cancer and the Immune System: A Double-Edged Sword

September 15, 2014 – 12:00 pm | Edit Post

During cancer development, tumor cells decorate their surfaces with sugar compounds called glycans that are different from those found on normal, healthy cells. Researchers at the University of California, San Diego School of Medicine report that sialic acids at the tips of these cancer cell glycans are capable of engaging with immune system cells and changing the latter’s response to the tumor – for good and bad.

Salk scientists find immune, cancer controllers

September 15, 2014 – 9:59 am | Edit Post

Finding about how the body removes dead cells may help with cancer, autoimmune diseases.

Salk scientists find immune, cancer controllers

September 15, 2014 – 9:59 am | Edit Post

Finding about how the body removes dead cells may help with cancer, autoimmune diseases.

Happy Monday Morning! It’s the Celsius Quiz.

September 15, 2014 – 9:34 am | Edit Post

Celsius Quiz Sept 14 Blood Cancer Awareness Month

Happy Monday Morning! It’s the Celsius Quiz.

September 15, 2014 – 9:34 am | Edit Post

Celsius Quiz Sept 14 Blood Cancer Awareness Month

Graduate Student Sany Hoxha: Captivated by Complexity

September 15, 2014 – 12:00 am | Edit Post

The aspiring cancer biologist decided to apply to TSRI’s graduate program after a summer internship at Scripps Florida.

Professor Dennis Burton: In Search of an Effective HIV/AIDS Vaccine

September 15, 2014 – 12:00 am | Edit Post

Developing an HIV vaccine has been the hope for more than 30 years—but the task has turned out to be more complicated than it initially appeared. TSRI Professor Dennis Burton is among those tasked with making an AIDS vaccine a reality.

Donor Eleanor Mosca: Explorer, Caregiver, Educator—and TSRI Supporter

September 15, 2014 – 12:00 am | Edit Post

Eleanor Mosca, a loyal TSRI supporter who has included the institute in her estate plan, says, “I contribute because I feel it’s the building block for improved health and saving lives.”

Viking Therapeutics Inc. Prices Planned IPO

September 14, 2014 – 4:06 pm | Edit Post

San Diego-based Viking Therapeutics Inc., a biotech company developing treatments for diabetes and metabolic disorders, has announced the estimated pricing of its initial public offering at $55 million – 5 million shares at a price range of $10 to $12.

Viking Therapeutics Prices Planned IPO

September 12, 2014 – 3:05 pm | Edit Post

San Diego-based Viking Therapeutics Inc., a biotech company developing treatments for diabetes and metabolic disorders, has announced the estimated pricing of its initial public offering at $55 million – 5 million shares at a price range of $10 to $12.